Effects of nonsteroidal anti-inflammatory drugs on prostacyclin and thromboxane in the kidney

Pharmacology

Volumn 68, Issue 3, 2003, Pages 147-153

  Lomnicka, Magdalena ^a   Karouni, Katayoun ^a   Sue, Michele ^a   Wessel, Lauren A ^a   Bing, Richard J ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Aspirin; Celecoxib; Nonsteroidal anti inflammatory drugs; Prostacyclin; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; MERCURIC CHLORIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; KIDNEY CORTEX; KIDNEY MEDULLA; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPOPROSTENOL; KIDNEY; MERCURIC CHLORIDE; PYRAZOLES; RABBITS; SULFONAMIDES; THROMBOXANES;

EID: 0038355057     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070172     Document Type: Article

References (22)

1. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J Biol Chem 1996;271:33157-33160.
2. Bing RJ, Lomnicka M: Why do cyclo-oxygenase-2 inhibitors cause cardiovascular events? J Am Coll Cardiol 2002;39:521-522.
3. Allison MC, Howatson AG, Torrance CJ, et al: Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992;327:749-755.
4. Mukherjee D, Nissen SE, Topol EJ: Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954-959.
5. Yamamoto T, Kakar NR, Vina ER, et al: Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ. Pharmacology 2001;63:28-33.
6. Miyataka M, Rich KA, Ingram M, et al: Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. Hypertension 2002;39:785-789.
7. Ross EM: Pharmacodynamics: Mechanisms of drug action and the relationship between drug concentration and effect; in Goodman & Gilman's (eds): The Pharmacological Basis of Therapeutics. New York, McGraw-Hill, 1996, pp 29-41.
8. Valtin H: Structural and functional heterogeneity of mammalian nephrons. Am J Physiol 1977;236:F491-F501.
9. Flamenbaum W, Hamburger RJ: Superficial and deep juxtaglomerular apparatus renin activity in the rat kidney: Effect of surgical preparation and NaCl intake. J Clin Invest 1974;54:1373-1381.
10. Goodyer AV, Jaeger CA: Renal response to nonshocking hemorrhage: Role of the autonomic nervous system and of the renal circulation. Am J Physiol 1955;180:69-74.
11. Jamison RL: Intrarenal heterogeneity: The case for two functionally dissimilar populations of nephrons in the mammalian kidney: Am J Med 1973;54:281-289.
12. Horster M, Thurau K: Micropuncture studies on the filtration rate of single superficial and juxtamedullary glomeruli in the rat kidney. Pflügers Arch Gesamte Physiol Menschen Tiere 1968;301:162-181.
13. Zalups RK: Renal accumulation and intrarenal distribution of inorganic mercury in the rabbit: Effect of unilateral nephrectomy and dose of mercuric chloride. J Toxicol Environ Health 1991;33:213-228.
14. ++-induced tubular necrosis and regeneration. Environ Health Perspect 1994;102(suppl 3):317-320.
15. Kyle GM, Luthra R, Bruckner JV, et al: Assessment of functional, morphological, and enzymatic tests for acute nephrotoxicity induced by mercuric chloride. J Toxicol Environ Health 1983;12:99-117.
16. Zalups RK: Early aspects of the intrarenal distribution of mercury after the intravenous administration of mercuric chloride. Toxicology 1993;79:215-228.
17. Dunn MJ: Are COX-2 selective inhibitors nephrotoxic? Am J Kidney Dis 2000;35:976-977.
18. Perazella MA, Eras J: Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 2000;35:937-940.
19. Kömhoff M, Gröne HJ, Klein T, et al: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function. Am J Physiol 1997;272:F460-F468.
20. Harris RC, McKanna JA, Akai Y, et al: Cyclooxygenase-2 is associated with the macula densa of the rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504-2510.
21. Yamamoto T, Cohen AM, Kakar NR, et al: Production of prostanoids and nitric oxide by the infarcted heart in situ and the effect of aspirin. Biochem Biophys Res Commun 1999;257:488-493.
22. Bing RJ: Myocardial ischemia and infarction: Growth of ideas. Cardiovasc Res 2001;51:13-20.